These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9282797)

  • 1. De novo mutation of the platelet glycoprotein Ib alpha gene in a patient with pseudo-von Willebrand disease.
    Kunishima S; Heaton DC; Naoe T; Hickton C; Mizuno S; Saito H; Kamiya T
    Blood Coagul Fibrinolysis; 1997 Jul; 8(5):311-5. PubMed ID: 9282797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and functional characterization of an abnormal platelet membrane glycoprotein Ib alpha (Met239 --> Val) reported in patients with platelet-type von Willebrand disease.
    Moriki T; Murata M; Kitaguchi T; Anbo H; Handa M; Watanabe K; Takahashi H; Ikeda Y
    Blood; 1997 Jul; 90(2):698-705. PubMed ID: 9226170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinguishing between type 2B and pseudo-von Willebrand disease and its clinical importance.
    Enayat MS; Guilliatt AM; Lester W; Wilde JT; Williams MD; Hill FG
    Br J Haematol; 2006 Jun; 133(6):664-6. PubMed ID: 16704444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-type von Willebrand disease and type 2B von Willebrand disease: a story of nonidentical twins when two different genetic abnormalities evolve into similar phenotypes.
    Othman M
    Semin Thromb Hemost; 2007 Nov; 33(8):780-6. PubMed ID: 18175283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel platelet-type von Willebrand disease mutation (GP1BA p.Met255Ile) associated with type 2B "Malmö/New York" von Willebrand disease.
    Lavenu-Bombled C; Guitton C; Dupuis A; Baas MJ; Desconclois C; Dreyfus M; Li R; Caron C; Gachet C; Fressinaud E; Lanza F
    Thromb Haemost; 2016 Nov; 116(6):1070-1078. PubMed ID: 27683759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, laboratory and therapeutic aspects of platelet-type von Willebrand disease.
    Franchini M; Montagnana M; Lippi G
    Int J Lab Hematol; 2008 Apr; 30(2):91-4. PubMed ID: 18333841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of platelet-type von Willebrand disease by flow cytometry.
    Giannini S; Cecchetti L; Mezzasoma AM; Gresele P
    Haematologica; 2010 Jun; 95(6):1021-4. PubMed ID: 19951970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation in the gene encoding the alpha chain of platelet glycoprotein Ib in platelet-type von Willebrand disease.
    Miller JL; Cunningham D; Lyle VA; Finch CN
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4761-5. PubMed ID: 2052556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitution of Val for Met at residue 239 of platelet glycoprotein Ib alpha in Japanese patients with platelet-type von Willebrand disease.
    Takahashi H; Murata M; Moriki T; Anbo H; Furukawa T; Nikkuni K; Shibata A; Handa M; Kawai Y; Watanabe K
    Blood; 1995 Feb; 85(3):727-33. PubMed ID: 7833477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of p.W246L as a novel mutation in the GP1BA gene responsible for platelet-type von Willebrand disease.
    Woods AI; Sanchez-Luceros A; Bermejo E; Paiva J; Alberto MF; Grosso SH; Kempfer AC; Lazzari MA
    Semin Thromb Hemost; 2014 Mar; 40(2):151-60. PubMed ID: 24474090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational energy analysis of the substitution of Val for Gly 233 in a functional region of platelet GPIb alpha in platelet-type von Willebrand disease.
    Pincus MR; Dykes DC; Carty RP; Miller JL
    Biochim Biophys Acta; 1991 Sep; 1097(2):133-9. PubMed ID: 1911886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of von Willebrand disease type IIB. Candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein Ib binding sequences.
    Randi AM; Rabinowitz I; Mancuso DJ; Mannucci PM; Sadler JE
    J Clin Invest; 1991 Apr; 87(4):1220-6. PubMed ID: 2010538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutations.
    de Romeuf C; Hilbert L; Mazurier C
    Thromb Haemost; 1998 Jan; 79(1):211-6. PubMed ID: 9459349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudo-von Willebrand disease: a mutation in the platelet glycoprotein Ib alpha gene associated with a hyperactive surface receptor.
    Russell SD; Roth GJ
    Blood; 1993 Apr; 81(7):1787-91. PubMed ID: 8384898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N1421K mutation in the glycoprotein Ib binding domain impairs ristocetin- and botrocetin-mediated binding of von Willebrand factor to platelets.
    Lanke E; Kristoffersson AC; Isaksson C; Holmberg L; Lethagen S
    Eur J Haematol; 2008 Nov; 81(5):384-90. PubMed ID: 18637125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidance on the diagnosis and management of platelet-type von Willebrand disease: A communication from the Platelet Physiology Subcommittee of the ISTH.
    Othman M; Gresele P
    J Thromb Haemost; 2020 Aug; 18(8):1855-1858. PubMed ID: 32279414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C1272S: a new candidate mutation in type 2A von Willebrand disease that disrupts the disulfide loop responsible for the interaction of VWF with platelet GP Ib-IX.
    Penas N; Pérez A; González-Boullosa R; Batlle J
    Am J Hematol; 2004 Feb; 75(2):73-7. PubMed ID: 14755371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetics of von Willebrand disease.
    Mazurier C; Ribba AS; Gaucher C; Meyer D
    Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel heterozygous missense mutation in the platelet glycoprotein Ib beta gene associated with isolated giant platelet disorder.
    Kunishima S; Naoe T; Kamiya T; Saito H
    Am J Hematol; 2001 Dec; 68(4):249-55. PubMed ID: 11754414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease.
    Stepanian A; Ribba AS; Lavergne JM; Fressinaud E; Juhan-Vague I; Mazurier C; Girma JP; Meyer D
    Br J Haematol; 2003 Feb; 120(4):643-51. PubMed ID: 12588351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.